DNA Link Inc

DNA Link Inc

127120 · KQ · Healthcare / Biotechnology

18,440.00KRW+310.00 (+1.71%)

Price History

Full chart

Market Stats

Previous Close18,130.00
Open18,030.00
Day Range17,850.00 – 19,450.00
52-Week Range13,860.00 – 49,900.00
Volume132.41K
Market Cap1.03T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.59
50-Day Avg33,582.00
200-Day Avg33,411.55

About

JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing. The company also provides microarray services, such as DNA and microarray RNA analysis; Fluidigm BioMark System, an automated PCR/qPCR system; TaqMan assay; and SNaPshot assay. In addition, it provides rare earth and permanent magnets. The company was formerly known as DNA Link, Inc. and changed its name to JS Link, Inc. in April 2025. JS Link, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOJong-Beom Lee Ph.D.
  • Employees84
  • Headquarters31, Magokjungang 8-ro 3-gil, Seoul, South Korea, Korea
  • Websitehttps://jslink.co.kr

Leadership

  • Jong-Beom Lee Ph.D.Executive Director, President & CEO · b. 1963
  • Sunghoon ChaExecutive Director

Financials

Income Statement

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.15B10.04B8.73B9.42B11.48B14.48B14.88B15.57B15.29B22.99B16.98B21.95B15.91B19.32B
Growth (%)-+9.69%-13.00%+7.87%+21.91%+26.09%+2.73%+4.68%-1.84%+50.41%-26.14%+29.26%-27.52%+21.43%
Cost of Revenue5.59B7.29B9.09B11.65B11.07B8.24B11.00B12.62B12.96B16.69B13.82B16.41B13.09B15.67B
Gross Profit3.56B2.75B-358.06M-2.23B417.24M6.24B3.88B2.95B2.33B6.30B3.16B5.54B2.81B3.65B
Gross Margin38.92%27.35%-4.10%-23.65%3.63%43.08%26.06%18.97%15.23%27.41%18.61%25.25%17.69%18.88%
Operating Expense2.17B2.44B3.89B6.16B8.91B5.29B8.28B11.69B12.89B12.37B12.04B10.90B17.87B15.84B
Operating Income1.39B307.00M-4.25B-8.39B-8.49B949.41M-4.40B-8.73B-10.56B-6.07B-8.88B-5.35B-15.06B-12.19B
Operating Margin15.18%3.06%-48.70%-89.09%-73.97%6.56%-29.59%-56.08%-69.09%-26.41%-52.30%-24.40%-94.65%-63.13%
EBITDA-----------6.13B-3.81B-8.60B-11.54B
EBITDA Margin-----------36.07%-17.36%-54.06%-59.74%
Net Income1.46B270.00M-4.46B-9.05B-9.81B337.62M-3.75B-13.12B-13.07B-5.10B-7.78B-5.60B-10.80B-16.45B
Net Income Margin15.93%2.69%-51.06%-96.12%-85.44%2.33%-25.23%-84.24%-85.48%-22.18%-45.82%-25.50%-67.90%-85.14%
R&D--193.80M1.03B584.74M538.50M104.38M355.96M463.83M538.94M465.02M84.63M18.90M28.38M
R&D as % of Total Revenue--2.22%10.92%5.09%3.72%0.70%2.29%3.03%2.34%2.74%0.39%0.12%0.15%
Interest Expense00000000534.63M41.64M59.21M258.18M569.07M2.14B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.50%0.18%0.35%1.18%3.58%11.08%

Balance Sheet

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets20.49B30.03B20.48B32.73B25.86B25.07B35.07B25.90B52.54B41.02B43.51B38.76B54.39B123.04B
Total Liabilities8.97B12.33B12.74B21.53B24.04B1.41B15.46B16.24B13.84B8.25B15.62B12.48B29.36B54.44B
Total Equity--7.73B11.20B1.82B23.66B19.60B9.66B38.70B32.77B27.89B26.28B25.03B68.59B
Cash3.35B3.69B2.00B2102.96B5.03B3906.40B36.95B10635.67M6.57B131.87M40.43B
Total Debt------2.78B2.59B2.31B-----
Net Debt-------3.30B----12.91B2.07B

Cash Flow

Currency: KRW2011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.44B-783.00M-143.14M-3.73B-3.77B-2.49B-1.60B-1.30B849.38M-6.43B910.27M-5.03B-6.78B-9.39B
Investing Cash Flow-4.99B-7.89B1.59B-13.13B-761.77M6.15B-3.51B-4.15B1.56B-23.08B-2.68B-3.72B-18.62B-
Financing Cash Flow9.80B9.02B-844.24M20.87B1.57B-1.57B11.88B31.67M28.24B-1.69B6.65B4.58B23.53B-
Capital Expenditure5.07B4.29B1.42B3.55B1.35B753.03M2.51B2.58B1.10B4.02B4.93B2.88B16.72B44.08B
Free Cash Flow--------5.16B-410.96M-10.47B-4.18B-7.92B-23.50B-53.47B
FCF to OCF-------397.06%-48.38%162.86%-458.86%157.51%346.57%569.63%

Earnings

Report DateMar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 25, 2016Nov 25, 2016Mar 30, 2017May 15, 2017Aug 7, 2017Nov 1, 2017Feb 13, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 12, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 5, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 23, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------
EPS Actual20.8430.70-20.0820.86-129.32-238.25-353.10-613.05-282.5224.57-63.73-503.06-332.61-2.77-154.57-862.28-370.02-398.40-395.24-419.002.84-70.5014.0061.30-29.89-116.69-138.08-44.08-131.85-180.60-104.52-698.59-87.16-204.34-173.23-413.77-70.52-116.7114.12-137.99-218.19-10.80-58.29-177.23-87.00-19.48-97.89-122.00-6.68-159.45-305.52-73.43-196.54-92.36-133.56-187.89-113.09-124.22
Surprise----------------------------------------------------------
Timing-----------------Pre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market----------------------

Key Statistics & Ratios

Market Cap1.03T
Enterprise Value1.10T
Trailing P/E0.00
Forward P/E0.00
Price / Sales45.07
Price / Book10.67
Revenue (TTM)22.78B
Gross Profit (TTM)5.74B
EBITDA-12.75B
Profit Margin-23.26%
Operating Margin-65.97%
Return on Equity-7.44%
Return on Assets-8.26%
Shares Outstanding34.74M
Shares Float23.76M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 28, 2020471:443